C85.78 Other specified types of non-Hodgkin's lymphoma, lymph nodes of multiple sites

Name of the Condition

• Other specified types of non-Hodgkin's lymphoma, lymph nodes of multiple sites
• C85.78

Summary

Other specified types of non-Hodgkin's lymphoma, lymph nodes of multiple sites, is a subtype of non-Hodgkin lymphoma (NHL) involving lymph nodes in more than one anatomical region. This code applies when the lymphoma type is known but not classified into a more specific subcategory, and the site of involvement is documented as multiple lymph node areas. NHL arises from abnormal lymphocyte growth in the lymphatic system, which is part of the immune system.

Causes

The exact cause of this condition is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in multiple areas (e.g., neck, armpits, groin)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Persistent cough or chest discomfort (if thoracic nodes are involved)
• Shortness of breath (if thoracic nodes are involved)

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT scans, PET scans), and biopsy of affected lymph nodes. Blood tests may assess overall health and detect abnormalities. Pathology reports confirm the lymphoma type, and staging determines the extent of disease spread. Documentation of multiple lymph node sites is critical for accurate coding.

Treatment Options

Treatment depends on the lymphoma subtype, stage, and patient health. Options may include chemotherapy, immunotherapy, radiation therapy, or targeted therapy. Clinical trials or combination therapies might be considered for specific cases. Treatment plans are tailored to the individual and monitored for response.

Prognosis and Follow-Up

Prognosis varies based on lymphoma subtype, stage, and patient factors. Regular follow-up with imaging and blood tests monitors for recurrence or progression. Long-term surveillance is often recommended, as some lymphomas may relapse. Early detection of complications or treatment side effects supports better outcomes.

Complications

Potential complications include infection due to weakened immunity, organ damage from lymph node enlargement, or treatment-related side effects (e.g., fatigue, nausea). Advanced disease may lead to systemic symptoms or impaired organ function. Prompt management of complications is essential.

Lifestyle & Prevention

Maintaining a healthy immune system through balanced nutrition, regular exercise, and stress management may support overall health. Avoiding known risk factors (e.g., unnecessary chemical exposure) and managing chronic conditions (e.g., HIV) can reduce risk. Vaccinations (e.g., flu, pneumonia) may be recommended to prevent infections.

When to Seek Professional Help

Seek medical attention for persistent swollen lymph nodes, unexplained weight loss, fever, or night sweats. Rapidly worsening symptoms (e.g., severe shortness of breath, chest pain) require immediate evaluation. Follow up with a healthcare provider for abnormal test results or treatment side effects.

Tips for Medical Coders

Use C85.78 when the diagnosis specifies non-Hodgkin's lymphoma of a type not classified into a more specific subcategory, with involvement of lymph nodes in multiple sites. Ensure documentation clearly identifies the lymphoma type and the multiple anatomical regions affected. Verify that no more specific code applies before assigning this code.